2,491 reports of this reaction
2.1% of all LIDOCAINE reports
#9 most reported adverse reaction
SINUSITIS is the #9 most commonly reported adverse reaction for LIDOCAINE, manufactured by Shenzhen Finona Information Technology Co., Ltd. There are 2,491 FDA adverse event reports linking LIDOCAINE to SINUSITIS. This represents approximately 2.1% of all 120,190 adverse event reports for this drug.
Patients taking LIDOCAINE who experience sinusitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SINUSITIS is a less commonly reported adverse event for LIDOCAINE, but still significant enough to appear in the safety profile.
In addition to sinusitis, the following adverse reactions have been reported for LIDOCAINE:
The following drugs have also been linked to sinusitis in FDA adverse event reports:
SINUSITIS has been reported as an adverse event in 2,491 FDA reports for LIDOCAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SINUSITIS accounts for approximately 2.1% of all adverse event reports for LIDOCAINE, making it a notable side effect.
If you experience sinusitis while taking LIDOCAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.